background
time
diagnost
investig
establish
microbi
etiolog
pneumonia
essenti
ensur
administr
effect
antibiot
therapi
individu
patient
method
evalu
multiplex
pcr
assay
panel
pneumonia
panel
filmarray
pp
biofir
diagnost
detect
respiratori
pathogen
resist
determin
compar
perform
standardofcar
test
intens
care
unit
patient
lower
respiratori
tract
infect
result
among
endotrach
aspir
bronchoalveolar
lavag
specimen
obtain
adult
patient
filmarray
pp
effect
detect
respiratori
bacteri
pathogen
overal
posit
percent
agreement
confid
interv
ci
neg
percent
agreement
ci
filmarray
pp
semiquantit
report
demonstr
concord
rate
cultureposit
specimen
cultureneg
specimen
filmarray
pp
detect
viral
journal
microbiolog
immunolog
infect
target
wherea
convent
viral
isol
fail
except
influenza
show
concord
pcr
coinfect
detect
specimen
substanti
discrep
observ
identifi
antimicrobi
resist
gene
target
suscept
test
howev
filmarray
pp
may
still
use
earli
stage
pneumonia
cultur
suscept
test
report
avail
consequ
result
filmarray
pp
might
alter
antibiot
prescript
patient
conclus
filmarray
pp
offer
rapid
sensit
diagnost
method
lower
respiratori
tract
infect
howev
clinic
correl
advis
determin
signific
interpret
multipl
pathogen
detect
gene
involv
antimicrobi
resist
pneumonia
lead
caus
hospit
death
global
accord
latest
avail
data
world
health
organ
lower
respiratori
tract
infect
fourth
common
caus
mortal
caus
million
death
worldwid
delay
antibiot
administr
advers
affect
prognosi
pneumonia
guidelin
recommend
earli
initi
antibiot
patient
pneumonia
sever
studi
suggest
surviv
benefit
antibiot
administ
within
h
present
diagnost
investig
establish
microbi
etiolog
pneumonia
essenti
ensur
administr
effect
antibiot
patient
howev
current
therapi
typic
initi
empir
basi
even
best
diagnost
method
caus
pathogen
often
detect
signific
proport
pneumonia
episod
etiolog
pneumonia
commun
epic
studi
report
pathogen
detect
rate
patient
hospit
pneumonia
use
tradit
diagnost
techniqu
includ
standard
cultur
antigen
detect
assay
nucleic
acid
detect
test
low
detect
yield
certainli
call
time
sensit
diagnost
tool
pathogen
identif
nonetheless
differenti
isol
true
pathogen
coincident
carriag
strain
lower
respiratori
tract
infect
remain
challeng
last
year
molecular
investig
emerg
diagnost
tool
choic
respiratori
pathogen
particularli
virus
owe
superior
sensit
detect
organ
difficult
isol
less
viabl
present
small
number
also
less
like
affect
prior
antibiot
administr
affect
standard
cultur
method
addit
molecular
diagnost
may
provid
addit
inform
regard
presenc
antibiot
resist
gene
may
promis
bettertarget
antimicrobi
therapi
improv
antibiot
stewardship
pneumonia
panel
filmarray
pp
biofir
diagnost
salt
lake
citi
ut
usa
multiplex
pcr
assay
panel
fdaapprov
multiplex
pcr
assay
allow
rapid
comprehens
detect
wide
rang
clinic
relev
target
resist
marker
sputum
includ
endotrach
aspir
bronchoalveolar
lavag
bal
specimen
target
list
includ
bacteria
atyp
bacteria
virus
antibiot
resist
gene
panel
also
provid
semiquantit
result
bacteria
may
aid
distinguish
clinic
relev
pathogen
colon
bacteria
normal
flora
base
estim
rel
nucleic
acid
abund
studi
first
evalu
clinic
perform
filmarray
pp
specimen
adult
lower
respiratori
tract
infect
compar
perform
standard
care
diagnost
investig
request
primari
care
physician
studi
includ
sputum
endotrach
aspir
bal
specimen
collect
march
june
patient
admit
medic
intens
care
unit
micu
nation
taiwan
univers
hospit
ntuh
respiratori
failur
hospit
tertiari
referr
hospit
locat
northern
taiwan
cater
clinic
divers
complex
patient
popul
includ
immunocompromis
host
undergo
solid
organ
hematopoiet
stem
cell
transplant
patient
cancer
cirrhosi
dialysi
immunodefici
enrol
subject
intub
henc
specimen
collect
endotrach
aspir
rather
expector
sputum
may
contamin
normal
flora
colon
upper
respiratori
tract
specimen
transport
clinic
microbiolog
laboratori
hospit
analysi
median
time
specimen
collect
load
filmarray
pouch
h
min
rang
min
h
min
chart
review
perform
determin
type
durat
antibiot
therapi
subject
studi
approv
institut
review
board
ethic
committe
nation
taiwan
univers
hospit
taipei
taiwan
sputum
specimen
subject
gram
stain
cultur
accord
standard
protocol
detect
common
respiratori
pathogen
convent
cultur
perform
inocul
bloodeosin
methylen
blue
agar
chocol
agar
incub
atmospher
enrich
co
c
cultur
plate
read
h
held
day
report
neg
isol
analyz
use
standard
biochem
method
bruker
biotyp
matrixassist
laser
desorptionion
timeofflight
mass
spectrometri
malditof
ms
system
suscept
test
perform
determin
minimum
inhibitori
concentr
mic
use
platform
inc
durham
nc
adenoviru
parainfluenza
viru
respiratori
syncyti
viru
chlamydia
identifi
direct
immunofluoresc
stain
oxoid
imagen
usa
serum
level
mycoplasma
pneumonia
igm
determin
use
rapid
immunochromatograph
test
anibiotech
finland
serum
pneumonia
igg
assay
use
enzymelink
immunosorb
assay
choru
kit
diess
diagnostica
senes
itali
urin
specimen
legionella
pneumococc
antigen
detect
perform
use
aler
binaxnow
urinari
antigen
card
usa
influenza
b
detect
fluoresc
immunoassay
sofia
quidel
usa
use
nasopharyng
swab
specimen
filmarray
pp
syndromespecif
cartridgebas
multiplex
pcr
includ
step
molecular
diagnost
autom
manner
aliquot
specimen
analyz
accord
manufactur
instruct
result
obtain
approxim
h
pneumonia
panel
compat
filmarray
panel
platform
principl
procedur
assay
describ
previous
result
antimicrobi
resist
gene
amr
report
qualit
condit
potenti
microorgan
gene
also
detect
sampl
exampl
mecac
mrej
report
presenc
aureu
detect
resist
marker
could
link
detect
microorgan
bacteria
report
semiquantit
nearest
whole
log
genom
copiesml
filmarray
pp
result
consid
concord
consist
result
convent
investig
semiquantit
analysi
bin
result
consid
concord
standardofcar
result
concord
moder
concord
mani
addit
posit
cultur
result
target
includ
filmarray
pp
result
observ
copiesml
present
amount
small
success
cultur
consid
concord
otherwis
result
filmarray
pp
discord
correspond
standardofcar
investig
filmarray
pp
result
consid
true
posit
true
neg
correspond
result
standardofcar
investig
posit
filmarray
pp
result
neg
cultur
repres
falseposit
wherea
posit
cultur
neg
filmarray
pp
consid
falseneg
posit
percent
agreement
ppa
calcul
true
posit
true
posit
fals
neg
neg
percent
agreement
npa
calcul
true
neg
true
neg
fals
posit
perform
measur
ppa
npa
refer
bacteri
analyt
gold
standard
bacteri
cultur
use
refer
method
total
endotrach
aspir
bal
specimen
adult
patient
admit
micu
includ
studi
seven
patient
underw
bronchoscopi
specimen
obtain
endotrach
tube
bronchoscopi
sent
analysi
among
patient
male
median
age
year
rang
year
respiratori
specimen
compris
sputum
endotrach
aspir
includ
specimen
bal
bronchial
wash
specimen
filmarray
pp
detect
least
one
pathogen
specimen
test
yield
posit
rate
tabl
summar
total
pathogen
resist
gene
detect
studi
panel
identifi
potenti
pathogen
bal
bronchial
wash
specimen
sputum
specimen
preval
pathogen
detect
k
pneumonia
p
aeruginosa
calcoaceticu
baumannii
complex
aureu
coinfect
includ
viru
detect
posit
specimen
greatest
number
pathogen
detect
singl
specimen
eight
acinetobact
baumannii
complex
e
aerogen
e
cloaca
complex
e
coli
k
pneumonia
p
aeruginosa
marcescen
aureu
multipl
detect
per
singl
specimen
higher
sputum
specimen
bal
bronchial
wash
specimen
tabl
virus
detect
specimen
influenza
commonli
detect
viru
follow
adenoviru
human
metapneumoviru
tabl
virus
bacteria
observ
togeth
n
z
specimen
six
virus
adenoviru
coronaviru
human
rhinovirusenteroviru
influenza
parainfluenza
viru
detect
bronchial
aspir
bal
specimen
multipl
virus
observ
specimen
catarrhali
proteu
spp
pyrogen
c
pneumonia
pneumonia
influenza
b
respiratori
syncyti
viru
detect
studi
among
respiratori
specimen
test
four
bla
ctxm
extendedspectrum
blactamas
esbl
three
carbapenemas
gene
bla
imp
bla
ndm
bla
vim
detect
perform
data
filmarray
pp
target
summar
tabl
ppa
npa
confid
interv
ci
filmarray
pp
refer
investig
respect
overal
concord
specimen
discord
specimen
yield
overal
agreement
filmarray
pp
show
concord
rate
five
target
follow
e
cloaca
complex
e
coli
h
influenza
marcescen
pneumonia
filmarray
pp
detect
l
pneumophila
two
specimen
serolog
test
fail
identifi
one
sputum
sampl
yield
k
oxytoca
report
filmarray
pp
five
analyt
demonstr
concord
rate
follow
calcoaceticu
baumannii
complex
k
pneumonia
group
p
aeruginosa
aureu
agalactia
catarrhali
proteu
spp
pyogen
c
pneumonia
pneumonia
detect
studi
therefor
ppa
npa
could
calcul
notabl
filmarray
pp
abl
detect
bacteria
cultureneg
specimen
specimen
patient
yield
bacteria
includ
filmarray
pp
burkholderia
cepacia
complex
citrobact
freundii
chryseobacterium
indologen
enterococcu
faecium
morganella
morganii
raoultella
ornithinolytica
ralstonia
manitolilytica
sphingomona
paucimobili
stenotrophomona
maltophilia
filmarray
pp
semiquantit
report
demonstr
concord
rate
cultureposit
specimen
cultureneg
one
tabl
overestim
quantif
observ
could
attribut
detect
dead
organ
filmarray
pp
filmarray
pp
detect
significantli
virus
adenoviru
coronaviru
human
metapneumoviru
human
rhinovirusenteroviru
parainfluenza
viru
standard
diagnost
method
virus
report
viral
cultur
identif
howev
influenza
demonstr
posit
agreement
nucleic
acid
test
includ
two
bal
specimen
four
bla
ctxm
detect
filmarray
pp
one
case
could
verifi
mic
method
list
tabl
correspond
pathogen
detect
standard
cultur
thu
sensit
test
perform
three
carbapenemas
observ
except
bla
vim
consist
mic
method
confer
penicillin
cephalosporin
carbapenem
resist
two
carbapenemresist
p
aeruginosa
one
baumannii
detect
cultur
antimicrobi
resist
gene
identifi
filmarray
pp
filmarray
pp
result
might
lead
deescal
initi
empir
antibiot
patient
filmarray
pp
combin
nest
multiplex
pcr
realtim
pcr
amplif
data
perform
nucleic
acid
extract
amplif
detect
data
analysi
dispos
pouch
system
provid
semiquantit
report
multiplex
molecular
assay
recent
fdaapprov
identif
respiratori
target
within
h
aid
diagnosi
lower
respiratori
tract
infect
prospect
studi
perform
characterist
filmarray
pp
estim
measur
agreement
standardofcar
diagnost
investig
overal
perform
filmarray
pp
compar
multiplex
respiratori
platform
overal
agreement
avail
target
test
bacteri
target
detect
gramneg
pathogen
gnb
virus
account
case
accord
local
epidemiolog
data
filmarray
pp
may
reach
approxim
coverag
preval
agent
respons
moder
sever
communityacquir
pneumonia
among
adult
taiwan
coverag
healthcareassoci
pneumonia
line
result
systemat
review
etiolog
agent
communityacquir
pneumonia
asia
reveal
high
preval
gnb
aureu
caus
pathogen
compar
commonli
observ
pneumonia
h
influenza
western
countri
incid
respiratori
tract
infect
caus
pneumonia
h
influenza
also
reduc
follow
implement
vaccin
program
among
elderli
children
addit
discrep
could
caus
fastidi
natur
h
influenza
difficult
cultur
studi
three
specimen
h
influenza
observ
filmarray
pp
recov
cultur
two
specimen
report
copiesml
bacteria
might
low
yield
posit
cultur
serolog
cultur
method
fail
identifi
two
l
pneumophila
found
filmarray
pp
diagnosi
legionella
infect
limit
difficulti
cultur
nonspecif
natur
serolog
investig
identifi
l
pneumophila
serogroup
speci
serogroup
discord
result
filmarray
pp
posit
cultureneg
studi
probabl
caus
antibiot
use
prior
sampl
nucleic
acid
organ
may
persist
vivo
independ
organ
viabil
detect
target
indic
correspond
organ
caus
agent
particular
clinic
symptom
likewis
perform
filmarray
pp
establish
monitor
treatment
infect
anoth
challeng
pose
molecular
diagnost
respiratori
pathogen
difficulti
distinguish
colon
infect
though
presenc
noncolon
organ
may
suggest
diseas
causat
certain
respiratori
pathogen
pneumonia
rhinoviru
adenoviru
may
colon
upper
airway
asymptomat
individu
thu
lead
diagnost
dilemma
quantif
microbi
load
molecular
method
may
provid
clue
isol
greater
quantiti
like
clinic
signific
defin
true
pathogen
respons
diseas
complic
detect
coinfect
studi
coinfect
viralbacteri
multipl
bacteri
pathogen
identifi
specimen
nevertheless
grow
evid
regard
incid
pathogenesi
polymicrobi
pneumonia
recent
major
revel
lung
microbiom
challeng
tradit
paradigm
lung
steril
pneumonia
caus
singl
invas
pathogen
futur
research
pneumonia
thu
need
address
conundrum
polymicrobi
respiratori
diseas
impact
pathogenesi
pneumonia
substanti
discrep
detect
antimicrobi
resist
gene
studi
multipl
genet
variant
mechan
resist
detect
resist
gene
impli
suscept
associ
antibiot
similarli
presenc
specif
genet
marker
link
pathogen
detect
complet
cultur
suscept
test
thu
perform
potenti
follow
recommend
guidelin
sever
limit
studi
could
address
notabl
one
lack
goldstandard
refer
method
clarifi
discrep
result
filmarray
pp
convent
investig
multiplex
pcr
like
better
sensit
tradit
cultur
serolog
investig
thu
lead
difficulti
interpret
clinic
signific
falseposit
result
therefor
inappropri
consid
posit
filmarray
pp
result
falseposit
compar
lesssensit
test
unavail
establish
refer
hinder
true
estim
accuraci
next
patient
enrol
studi
highli
heterogen
patient
variou
caus
respiratori
failur
includ
communityacquir
pneumonia
healthcareassoci
pneumonia
ventilatorassoci
pneumonia
noninfecti
lung
diseas
requir
intub
ventilatori
support
includ
studi
respiratori
specimen
obtain
intub
patient
repres
site
infect
less
like
contamin
upper
airway
flora
pathogen
respons
clinic
context
differ
may
part
target
panel
instanc
nosocomi
pathogen
maltophilia
b
cepacia
complex
elizabethkingia
meningoseptica
might
outgrow
common
caus
bacteria
result
antibiot
select
therebi
lead
underdetect
includ
panel
pathogen
pneumocysti
jiroveci
nontubercul
mycobacteria
also
includ
panel
commonli
caus
respiratori
infect
immunocompromis
host
taiwan
howev
enabl
us
understand
applic
filmarray
pp
across
differ
patient
popul
summari
filmarray
pp
may
provid
earli
inform
caus
pathogen
determin
resist
allow
pathogendirect
antibiot
therapi
coverag
preval
bacteria
caus
moder
sever
communityacquir
pneumonia
among
adult
taiwan
although
filmarray
pp
may
replac
convent
cultur
antimicrobi
suscept
test
especi
bacteri
target
still
effici
adjunct
guid
clinic
decis
antibiot
treatment
earli
stage
pneumonia
none
declar
